An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer

An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer

Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage IIA patients are usually spared the adjuvant chemotherapy, some of them relapse and may benefit from...

Full description

Bibliographic Details
Main Authors: Eva Budinská, Martina Čarnogurská, Tina Catela Ivković, Táňa Macháčková, Marie Boudná, Lucie Pifková, Ondřej Slabý, Beatrix Bencsiková, Vlad Popovici
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
colon cancer
invasion front
early stage
prognostic signature
stage II/MSS
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1367231/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1367231/full

Similar Items